Total planned funding: $88,724,064
Allocations
Countries/Regions
Burundi | $88,724,064 |
Organizational Types
NGO | $39,737,321 |
Private Contractor | $23,628,772 |
Unknown | $10,126,015 |
Own Agency | $8,311,466 |
University | $6,621,309 |
Other USG Agency | $299,181 |
Program Areas
Treatment | $24,584,844 |
Governance and Systems | $19,325,712 |
Prevention | $14,957,916 |
Testing | $13,555,743 |
Care | $10,989,240 |
Management and Operations | $5,310,609 |
Budget Codes
HTXS: Treatment: Adult Treatment | $15,080,803 |
HVCT: Testing: HIV Testing and Counseling | $13,555,743 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $9,199,451 |
OHSS: Health Systems Strengthening | $8,273,905 |
HTXD: Treatment: ARV Drugs | $6,900,436 |
HKID: Care: Orphans and Vulnerable Children | $6,222,365 |
HVSI: Strategic Information | $5,555,032 |
HLAB: Laboratory Infrastructure | $5,496,775 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,371,953 |
HVMS: Management and Operations | $5,310,609 |
HBHC: Care: Adult Care and Support | $2,621,475 |
PDTX: Treatment: Pediatric Treatment | $2,603,605 |
PDCS: Care: Pediatric Care and Support | $1,129,788 |
HVTB: Care: TB/HIV | $1,015,612 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $386,512 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
FHI 360:
$34,075,428
Countries/Regions
Chemonics International:
$13,908,004
Countries/Regions
Not Available:
$6,945,566
Countries/Regions
USG Aggregated Agencies:
$4,245,202
Countries/Regions